1 / 22

Methotrexate Never Event Presentation Date November 2015

Methotrexate Never Event Presentation Date November 2015. Christine Dodd Medication Safety Pharmacist Martin Shepherd Medicines Information & Clinical Economy. Methotrexate Never Event. Risk Description & Patient Outcome Never Event Chronology Root Cause

thomasdaniel
Download Presentation

Methotrexate Never Event Presentation Date November 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Methotrexate Never Event Presentation Date November 2015 Christine Dodd Medication Safety Pharmacist Martin Shepherd Medicines Information & Clinical Economy

  2. Methotrexate Never Event • Risk Description & Patient Outcome • Never Event • Chronology • Root Cause • Demonstration of JAC EPMA Prescription Modification • JAC EPMA re-configuration • Lessons Learned & Recommendations • Sharing the Learning

  3. Risk Description • JAC EPMA system configuration error resulting in methotrexate once weekly dose being administered inadvertently twice in one week • Level of patient harm; Low • Patient followed-up by Consultant Haematologist (out-patient appointment)

  4. Never Event Over dose of methotrexate for non-cancer patients • Overdose refers to  When a patient receives methotrexate ,via any route, for non-cancer treatment which results in more than the intended weekly dose being taken, despite the care setting having an electronic prescribing and administration system , or in primary care an electronic prescribing and dispensing system, in place • Setting: All patients receiving NHS funded care. • Guidance: • - Patient safety alert - Improving compliance with oral methotrexate guidelines, 2006, available at http://www.nrls.npsa.nhs.uk/resources/?entryid45=59800

  5. Chronology

  6. Chronology

  7. Root Cause • The incident was associated with a system configuration error within JAC EPMA

  8. Re-configuration

  9. Re-configuration

  10. Re-configuration

  11. Re-configuration

  12. Re-configuration

  13. Re-configuration

  14. Re-configuration

  15. Opportunities for Prevention • Pharmacist review of prescription following modification • Nurse checking of previous dose for weekly doses • Working with JAC to mitigate risk re-occuring at other Trusts

  16. Share the learning • Escalation to JAC EPMA • Escalation to MSO network • Sharing at the NHS England EPMA WebEx event • Instalment of high alert flags with V2014 upgrade • Reconfiguration of JAC EPMA • Pharmacy training & Duty of Candour • Publish Safe Medication Practice Bulletin • Trust meetings: F1 training, Sister’s and Matrons

  17. Thank you Any Questions?

More Related